ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PARADIGM RECEIVES $2.32m R&D TAX INCENTIVE REFUND
Published: 15/11/18, 08:29am (AEST)•1 pages